From clinical to human toxicology: Linking animal research and risk assessment in man

Toxicology Letters

Volumn 140-141, Issue , 2003, Pages 3-10

  Descotes, Jacques ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Clinical toxicology; Experimental toxicology; Immunotoxicology; Poison center; Risk assessment; Toxicovigilance

Indexed keywords

ACETYLCYSTEINE; ANTIBODY; ANTIDOTE; XENOBIOTIC AGENT;

ALLERGIC REACTION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; INTOXICATION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; RISK ASSESSMENT; TOXICITY; TOXICOLOGY;

ANIMALIA;

EID: 17344392438     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00490-3     Document Type: Conference Paper

References (46)

1. Criteria for certification as a regional poison center. Vet. Hum. Toxicol. 30:1988;395-397.
2. Antman E.M., Wenger T.L., Butler V.P., Haber E., Smith T.W. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Circulation. 81:1990;1744-1752.
3. Barlow S.M., Greig J.B., Bridges J.W., Carere A., Carpy A.J., et al. Hazard identification by methods of animal-based toxicology. Food Chem. Toxicol. 40:2002;145-191.
4. Bessems J.G., Vermeulen N.P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 31:2001;55-138.
5. Bismuth C., Borron S.W., Baud F.J., Taboulet P., Scherrmann J.M. Immunotoxico-therapy: successes, disappointments and hopes. Hum. Exp. Toxicol. 16:1997;602-608.
6. Cadot R., Descotes J., Cuilleron C.Y., Grenot C., Evreux J.Cl. Evaluation of active specific immunization against paraquat toxicity in rats. Vet. Hum. Toxicol. 28:1986;226-229.
7. Choquet-Kastylevski G., Descotes J. Value of animal models for predicting hypersensitivity reactions to medicinal products. Toxicology. 129:1998;27-35.
8. Choquet-Kastylevsky G., Vial T., Descotes J. Diagnosis of drug allergy in humans: possibilities and pittfalls. Toxicology. 158:2001;1-10.
9. Clemmesen C. New line of treatment in barbiturate poisoning. Acta Med. Scand. 148:1954;83-89.
10. Dally S., Alperovitch A., Lagier G., Bismuth C., Fournier E. Prognostic factors in acute digitalis poisoning. Nouv. Presse Méd. 10:1981;2257-2260.
11. De Rosa F.G., Bonora S., Di Perri G. Tuberculosis and treatment with infliximab. N. Engl. J. Med. 346:2002;623-626.
12. Descotes J. Adverse consequences of chemical immunomodulation. Clin. Res. Pract. Drug Regul. Affairs. 3:1985;45-52.
13. Descotes J. Immunotoxicity of Drugs and Chemicals. 1988;Elsevier, Amsterdam.
14. Descotes J. Clinical immunotoxicology. J. Toxicol. Clin. Toxicol. 25:1988;7-8.
15. Descotes J. Human Toxicology. 1996;Elsevier, Amsterdam.
16. Descotes J., Nicolas B., Vial T., Nicolas J.-F. Biomarkers of immunotoxicity in man. Biomarkers. 1:1996;77-80.
17. Descotes J. Autoimmunity and toxicity testing. Toxicol. Lett. 112/113:2000;461-465.
18. Descotes J., Cadot R., Evreux J.Cl., Grenot C., Cuilleron C.Y. Immunological protection against ajmaline toxicity. J. Immunopharmacol. 3:1981;111-117.
19. Evreux J.-Cl., Prost G., Descotes J., Bergeret A. Method for the assessment of diagnosis in toxicology. Regul. Toxicol. Pharmacol. 7:1987;169-178.
20. Heard K., O'Malley G.F., Dart R.C. Treatment of amitriptyline poisoning with ovine antibody to tricyclic antidepressants. Lancet. 354:1999;1614-1615.
21. International Programme on Chemical Safety, 1988. Guidelines for Poison Information Centres. Their Role in Prevention and Response to Poisonings. World Health Organization, Geneva.
22. Jaffery F.N., Misra V., Viswanathan P.N. Convergence of clinical toxicology and epidemiology in relation to health effects of chemicals. Environ. Toxicol. Pharmacol. 12:2002;169-179.
23. Kerkvliet N.I. Immunological effects of chlorinated dibenzo-p-dioxins. Environ. Health Perspect. 103:(Suppl. 9):1995;47-53.
24. Klaassen C.D. Casarett and Doull's Toxicology. The Basic Science of Poisons. sixth ed. 2001;McGraw-Hill, New York.
25. Lall S.B., Peshin S.S. Role and functions of Poisons Information Centre. Indian J. Pediatr. 64:1997;443-449.
26. Lovejoy F.H. Clinical toxicology built better than they knew. Reflections on yesterday, today and tomorrow. Internet J. Med. Toxicol. 32:2000;2. http://www.ijmt.net.
27. Maurer T. Contact and Photocontact Allergens. 1983;Marcel Dekker, New York.
28. Meyler L. Side effects of drugs. Meyler L. Cytotostatic Drugs. 1966;472-494 Excerpta Medica, Amsterdam.
29. Mutti A. Biological monitoring in occupational and environmental toxicology. Toxicol. Lett. 108:1999;77-89.
30. Norval, M., Garssen, J., Van Loveren, H., ElGhorr, A.A., 1999. UV-induced changes in the immune response to microbial infections in human subjects and animal models. J. Epidemiol. Suppl., S84-S92.
31. Ochs H.R., Vatner S.F., Smith T.W. Reversal of inotropic effects of digoxin by specific antibodies and their Fab fragments in the conscious dog. J. Pharmacol. Exp. Ther. 207:1978;64-71.
32. Orfila, M.J.B., 1814. Traité des poisons tirés des règnes minéral, végétal et animal, ou Toxicologie générale considérée sous les rapports de la physiologie, de la pathologie et de la médecine légale. Crochard, Paris.
33. Prescott L.F. Paracetamol: past, present, and future. Am. J. Ther. 7:2000;143-147.
34. Prescott L.F., Illingworth R.N., Critchley J.A.J.H., Stewart M.J., Adam R.D., et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamaol poisoning. Br. Med. J. 2:1979;1097-1100.
35. Proudfoot A.T. Clinical toxicology: past, present and future. Hum. Toxicol. 7:1988;481-488.
36. Proudfoot A.T., Stewart M.S., Levitt T., Widdop B. Paraquat poisoning: significance of plasma paraquat concentrations. Lancet. ii:1979;330-332.
37. Smilkstein M.J., Knapp G.L., Kulig K.W., Rumack B.H. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N. Engl. J. Med. 319:1988;1557-1562.
38. Taubes G. Epidemiologiy faces its limits. Science. 269:1995;164-169.
39. Thomas S.H. Paracetamol (acetaminophen) poisoning. Pharmacol. Ther. 60:1993;91-120.
40. Timbrell A. Biomarkers in toxicology. Toxicology. 129:1998;1-12.
41. Urtizberea M., Sabouraud A., Cano N., Grandgeorge M., Rouzioux J.M., Scherrmann J.M. Reversal of murine colchicine toxicity by colchicine-specific Fab fragments. Toxicol. Lett. 58:1991;193-198.
42. Vale J.A., Meredith T.J. Clinical toxicology in the 1990s: the development of clinical toxicology centers - a personal view. Clin. Toxicol. 31:1993;222-223.
43. Vial T., Chevrel G., Descotes J. Drugs acting on the immune system. Dukes M.N.G., Aronson J.K. Meyler's Side-Effects of Drugs. 14th ed. 2000;1246-1337 Elsevier, Amsterdam.
44. Vial T., Nicolas B., Descotes J. Drug-induced autoimmunity. Experience of the French pharmacovigilance system. Toxicology. 119:1997;23-27.
45. Van Loveren H., De Jong W.H., Vandebriel R.J., Vos J.G., Garssen J. Risk assessment and immunotoxicology. Toxicol. Lett. 102-103:1998;261-265.
46. Zbinden G. Predicitive value of animal studies in toxicology. Regul. Toxicol. Pharmacol. 14:1990;167-177.